Compare Fusion Antibodies vs Sorrento Therapeutics
Customers evaluate the quality of Fusion Antibodies's products using the following success metrics.
Overview
Fusion Antibodies is 23 yrs old and is based in United Kingdom.
Fusion Antibodies uses technology to rapidly produce fusion proteins from genes and uses these products as antigens for the production and purification of antibodies.
Sorrento Therapeutics is based in United States
Sorrento Therapeutics (NASDAQ: SRNE) is a development-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary biotherapeutics for the treatment of a variety of disease conditions, including cancer, inflammation, metabolic, and infectious diseases. STI's objective is to identify drug development candidates derived from its proprietary human antibody libraries and, either independently or through partnerships, advance selected targets into preclinical or clinical development.
Demo Video
Leadership
James A Fair (Chief Financial Officer)
Henry H. Ji (Chief Executive Officer, President)
Funding
Investors
Gresham House Ventures, QUBIS
Paycheck Protection Program, QuickByte
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Fusion Antibodies has not claimed their profile.
Work for Fusion Antibodies? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Fusion Antibodies?
Claim your profile now.
Information not available because Sorrento Therapeutics has not claimed their profile.
Work for Sorrento Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Sorrento Therapeutics?
Claim your profile now.
Expert Collections
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.